Allogene Therapeutics ALLO Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Allogene Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's operating margin?
- Allogene Therapeutics (ALLO) reported operating margin of -1,241,813.6% in Q4 2024.
- How has Allogene Therapeutics's operating margin changed year-over-year?
- Allogene Therapeutics's operating margin decreased by 260.0% year-over-year, from -344,986.3% to -1,241,813.6%.
- What is the long-term trend for Allogene Therapeutics's operating margin?
- Over 3 years (2021 to 2024), Allogene Therapeutics's operating margin has grown at a 1882.2% compound annual growth rate (CAGR), from -159.4% to -1,241,813.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.